Compare Charles River Laboratories Intl. Inc (CRL) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs United Airlines Holdings Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $232.76 (market cap $11.14B), while United Airlines Holdings Inc trades at $122.4 (market cap $39.06B). The key difference: United Airlines Holdings Inc is far larger — about 3.5× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| CRL | UAL | |
|---|---|---|
Market Cap | $11.14B | $39.06B |
Sector | Health | Industrials |
52-Week High | $233.60 | $136.11 |
52-Week Low | $145.57 | $84.57 |
Enterprise Value | $14.00B | $55.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
United Airlines (UAL) trades at $121.16, down 3.84% amid sector volatility, with strong fundamentals including a P/E of 10.84 and net income margin of 6.06%. Recent earnings beats and a bullish analyst consensus (66% buy ratings) support a $160.88 price target. Cash flow trends show operational strength despite net outflows, while technical indicators signal near-term support at $120.
Outlook remains positive with projected revenue growth to $60.5B in 2026, though risks include fuel cost spikes and competitive pressures. The stock offers value with low valuation multiples and consistent earnings outperformance, positioning it for recovery if macroeconomic headwinds ease.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
